Cleared Special

K042281 - MODIFICATION TO ACCESS HYPERSENSITIVE HTSH ASSAY (FDA 510(k) Clearance)

Sep 2004
Decision
23d
Days
Class 2
Risk

K042281 is an FDA 510(k) clearance for the MODIFICATION TO ACCESS HYPERSENSITIVE HTSH ASSAY. This device is classified as a Radioimmunoassay, Thyroid-stimulating Hormone (Class II - Special Controls, product code JLW).

Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on September 16, 2004, 23 days after receiving the submission on August 24, 2004.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1690.

Submission Details

510(k) Number K042281 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 2004
Decision Date September 16, 2004
Days to Decision 23 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JLW — Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1690

Similar Devices — JLW Radioimmunoassay, Thyroid-stimulating Hormone

Atellica® IM TSH3-Ultra II (TSH3ULII)
K251543 · Siemens Healthcare Diagnostics, Inc. · Feb 2026
Dimension LOCI Thyroid Stimulating Hormone Flex reagent cartridge (TSHL)
K243570 · Siemens Healthcare Diagnostics · Apr 2025
ADVIA Centaur® TSH3-Ultra II (TSH3ULII)
K233050 · Siemens Healthcare Diagnostics, Inc. · Apr 2024
Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP)
K222116 · Siemens Healthcare Diagnostics, Inc. · Jul 2023
Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer
K221225 · Beckman Coulter, Inc. · Nov 2022